(Q39416235)

11 September 2017

Chronic hypoxia induces androgen-independent and invasive behavior in LNCaP human prostate cancer cells (English)

1 reference

11 September 2017

0 references

1 reference

Mutsushi Yamasaki

1

1 reference

11 September 2017

Takeo Nomura

series ordinal

2

1 reference

11 September 2017

Fuminori Sato

series ordinal

3

1 reference

11 September 2017

Hiromitsu Mimata

series ordinal

4

1 reference

11 September 2017

5 January 2012

1 reference

11 September 2017

1 reference

11 September 2017

31

1 reference

11 September 2017

7

1 reference

11 September 2017

1124-1131

1 reference

Prostate cancer epidemiology

11 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.007

Targeting the androgen receptor: improving outcomes for castration-resistant prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.007

Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.007

Hypoxia--a key regulatory factor in tumour growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.007

Hypoxic regions exist in human prostate carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.007

Increasing levels of hypoxia in prostate carcinoma correlate significantly with increasing clinical stage and patient age: an Eppendorf pO(2) study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.007

Hypoxic prostate/muscle pO2 ratio predicts for biochemical failure in patients with prostate cancer: preliminary findings.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.007

Going malignant: the hypoxia-cancer connection in the prostate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.007

Tumor hypoxia and the progression of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.007

Acute hypoxia increases the aggressive characteristics and survival properties of prostate cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.007

Hypoxia increases androgen receptor activity in prostate cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.007

The development of androgen-independent prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.007

Hypoxia selects for androgen independent LNCaP cells with a more malignant geno- and phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.007

Increased cell growth and tumorigenicity in human prostate LNCaP cells by overexpression to cyclin D1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.007

How matrix metalloproteinases regulate cell behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.007

New functions for the matrix metalloproteinases in cancer progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.007

Matrix metalloproteinases in tumor-host cell communication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.007

Matrix metalloproteinases: roles in cancer and metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.007

Hypoxia stimulates breast carcinoma cell invasion through MT1-MMP and MMP-2 activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.007

10.1016/J.UROLONC.2011.12.007

7 January 2021

Identifiers

DOI

1 reference

11 September 2017

1 reference